{
  "trial_id": "NCT00004850",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Blood donors will be enrolled from among participants in the blood programs of the National Institutes of Health/Clinical Center/Department of Transfusion Medicine (NIH/CC/DTM) and the American Red Cross/Central Maryland Chapter/The Greater Chesapeake and Potomac Regional Blood Services (ARC).",
      "label": "met"
    },
    {
      "criterion": "Enrollment will be restricted to those who test positive in the anti-HCV screening assay.",
      "label": "met"
    },
    {
      "criterion": "The donor must be anti-HCV+ at the time of donation or otherwise be identified as having acute hepatitis C virus infection (Or, b) Have HBV infection as evidenced by the presence of HBsAg and/or HBV DNA with or without coexistent HCV infection.",
      "label": "met"
    },
    {
      "criterion": "The donor must be 18 years of age or older.",
      "label": "met"
    },
    {
      "criterion": "The donor must be able/willing to travel to NIH for blood sampling 4 times in the first year of study and semi-annually thereafter and willing to have an annual history and physical examination.",
      "label": "met"
    },
    {
      "criterion": "The donor must be willing and able to provide informed consent.",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Donors who do not consent or who do not meet eligibility criteria will be excluded from the study with appropriate explanation.",
      "label": "triggers"
    }
  ],
  "notes": "The patient has a history of HCV and recent coinfection with HBV, but no other significant medical conditions. He is on treatment for HCV and has a negative biopsy for hepatocellular carcinoma.",
  "_meta": {
    "topic_id": "64",
    "trial_id": "NCT00004850",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}